Brighton Jones LLC Oncternal Therapeutics, Inc. Transaction History

Brighton Jones LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$0.28 - $0.79 $855 - $2,412	3,054 Added 0.91%	338,491 $115,000
Q1 2023 May 08, 2023	BUY	$0.63 - $1.3 $984 - $2,030	1,562 Added 0.47%	335,437 $264,000
Q4 2022 Feb 02, 2023	SELL	$0.86 - $22.2 $153 - $3,951	-178 Reduced 0.05%	333,875 $333,000
Q3 2022 Nov 09, 2022	BUY	$0.83 - $17.8 $147 - $3,168	178 Added 0.05%	334,053 $298,000
Q3 2021 Nov 04, 2021	BUY	$3.37 - $4.76 $3,370 - $4,760	1,000 Added 0.3%	333,875 $1.39 Million
Q1 2021 May 07, 2021	BUY	$4.59 - $9.04 $1.53 Million - $3.01 Million	332,875 New	332,875 $2.77 Million

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.